Les névrites microangiopathiques dans la lèpre
DOI:
https://doi.org/10.47878/hi.1977.v2.35654Palabras clave:
Hanseniasis, Hansenic neuritis, Microangiopathic neuritis, Microangiopathy Erythema nodosum hansenicum, Borderline hanseniasisResumen
Besides the typical hansenic neuritis characterized by a hypertrophic nerve associated with the already well known wide range of neural impairment, there are also microangiopathic lesions. Microangiopathic neuritis have been described by the author together with Camain and Maydat, in borderline and reactional (E.N.L.) cases (1966-1969). From the author's observations in the years 1970-1976, primary and secondary, acute and slow varieties of microangiopathic neuritis could be identified and systematized, both in borderline and E.N.L. cases. The clinical, immunological, pathological and therapeutical aspects of these microangiopathic neuritis are presented.
Descargas
Los datos de descargas todavía no están disponibles.
Citas
1. ARNOLD, J. Le petit lymphocyte: son rôle dans les réactions immunitaires. Med. Afr. Noire, 26(6): 375-387, 1976.
2. BARNETSON, R.; BARNETSON, A.; PEARSON, J. M. H.; KRONVALL, G Does nonspecific T-lymphocyte stimulation of B. lymphocytes occur during reversal reactions in bordeline leprosy?Scand. J. Immunol., 5(3): 287-291, 1976.
3. BARNETSON, R. S. G.; BRINE, G.; PEARSON, J. M. H.; KRONVALL, G Antigenic heterogeneity in patients with reactions in bordeline leprosy. Brit. Med. J., 22: 435-437, 1975.
4. BASTIN, R.; CHARMONT, G.; BONIZZONI, D.; GIROUIN, D.; KERNBAUM, S.; BRICAIRE.. F.; DIF, A. La lépre lepromateuse. Contre-indication méconnue de la vaccination antivariolique. Nouv. Presse Med., 5(17):1143-1144, 1976.
5. BENSASSON, M. Les neuropathies périphériques. Le Contours médica!, 98(47): 7549, 1976.
6. BENSOUSSAN, D.; LEVY-TOLEDANO, S.; PASSA, P. Anomalies de l'hémostase primaire au cours de la microangipathie diabétique. Nouv. Presse Med., 5(36): 2383-2386, 1976.
7. BERNARD, J. C. Estudio anatomopatologi co de las lesions vasculares del lepromatoso. Leprologia, 18(3): 239-267, 1973.
8. BODDINGIUS, J. Ultrastructural changes in blood vessels of peripheral nerves in leprosy neuropathy. 1. Tuberculoid and bordeline-Tuberculoid leprosy patients. Acta Neuropathol. (Berl), 35: 159-181, 1976.
9. BOUSSER, M. G. L'offensive des antiagrégants plaquettaires. L'année du Praticien, 26(59): 4265-4271, 1976.
10. CARAYON, A. Gamme lésionnelle des névrites hanséniennes. (Etat actuei des acquisitions récentes et des orientations thérapeutiques). Méd. Trop., 36(1): 41-61, 1976.
11. CARAYON, A.; CAMAIN, R.; BOURREL, P.; COLOMAR, R. Confrontationanatomo-clinique et angiopathique pour multinévrite tuber culoide réactionnelle. C. R. Trim. Inst. Marchoux, 7(3): 14-22, 1966; Bull. Soc. Med. Afr. Noire Lang. Fr., 11(2): 273-281, 1966.
12. CARAYON, A. & LANGUILLON, J. Traitement de la lépre tuberculoide par les sulfamides, retard. Afr. Méd., 44: 599, 1966.
13. CARAYON, A.; LANGUILLON, J.; GIRAUDEAU, P.; CAMAIN, R.; MAYDAT, L. Névri - tes micro-angiopathiques d'origine auto-immume probable après migrations inverses dans la zone bordeline du spectre de la lépre. Méd. Trop. 36(1): 16-33, 1976.
14. CARAYON, A.; LANGUILLON, J.; MAYDAT, L.; FAYE, I.; BOURGES, M. Deuxcasd'abces. lépromateux aigus du nerf cubital. Bull.Soc. Med. Afr. Noire Lang. Fr., 14(4) : 659-662, 1969.
15. CHOVET, M.; LUCOT, J.; SAINT-ANDRE, P.; VINGTAIN, P. Lesatteintesoculairesdansla lépre. Med. Trop. 36(1): 34-40, 1976.
16. CONN. D. L.; MCDUFFIE, F. C.; HOLLEY, K. E.; SCHROETER, A. L. Immunologic mechanisms in systemic vasculitis. Mayo Clin. Proc., 51: 511-518, 1976.
17. CONTAMIN, F.; SINGER, B.; MIGNOT, B.; ECOFFET, M.; KAZATCHKINE, M. Polineuropathie à rechutes. Rev. Neurol., (Paris) 132(11): 741-762, 1976.
18. DIEBOLD, J. & CAMILLERI, J. P. Macro et micro-angiopathies diabétiques. Aspects anatomopathologiques. Rev. Praticien, 26(45): 3075-3082, 1976.
19. GANDULY, R.; CUSUMANO, C. L.; WALDMAN, R.H. Suppression of cell-mediated immunity after infection with attenuated rubela virus. Infect. Immun.. 13(2): 464-469, 1976.
20. GHOSH, S. & KUNDU, K. K. Nerve abcess in lepromatous leprosy. Leprosy India, 41(1) : 11-13, 1969. i'
21. GUPTA, M.; BHARGAVA, M.; KUMAR, S.; MITTAL, M. M. Platelet function in leprosy. Int. J. Lepr., 43(4): 327-332, 1975.
22. HAUTECOUVERTURE, M.; BASDEVANT, A.; SLAMA, G.; TCHOBROUTSCKY, G. Etiopathogénie, physiopathologie et épidémiologie de la micro-angiopathie diabètique. Rev. Praticien, 26(45): 3085-3093, 1976.
23. KAUR, S.; WAHI, P. L.; CHAKRAVARTI, R. N.; SODHI, J. S.; VADHWA, M. B.; KHERA, A. S. Peripheral vascular deficit in leprosy. Int. J. Lepr., 44(3): 332-339, 1976.
24. LAMBERT, P. H. & MIESCHER, P. A. Aspect dynamique de la pathogénie des vasculites d'origine immunologique. Schweiz. Med. Wochenschr., 101: 1797-1798, 1971.
25. LETONTURIER, P. La microangiopathie diabétique. Nouv. Presse Méd., 5(36): 2365-2366, 1976.
26. MEHRA, N. K.; DASGUPTA, A.; VAIDYA, M. C. An evaluation of the immune state in leprosy. Leprosy India, 48(3): 231-237, 1976.
27. MUNSTER, A. M. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet, 1(7973): 1329-1330, 1976.
28. PARDO CASTELLO, V. & PINEYRO, R. Los cambios anatomo-patologicos de los nervios en la lepra lepromatosa. Rev. Sifil. Leprol. Dermatol., 5(2): 265-269, 1948.
29. PARMASWARAN, M.; GIRDHAR, B. K.; DEO, M. G.; KANDHARI, K. C.; BHUTANI, L. K. Macrophage function in leprosy. Int. J. Lepr., 44(3): 340-345, 1976.
30. PEARSON, J. M. H. & ROSS, W. F. Nerve involvement in leprosy. Pathology, differential diagnosis and principles of management. Lepr. Rev., 46(3): 199-212, 1975.
31. PIRART, J. Place et responsabilités des lesions vasculaires dans les neuropaties diabétiques. Rev. Praticien, 26(45): 3149-3156, 1976.
32. POLLARD, J. D.; KING, R. H.; THOMAS P. K. Recurrent experimental allergic neuritis. An electron microscope study. J. Neurol. Sci., 24(3): 365-383, 1975.
33. REVOL, L.; DECHAVANNE, M.; LAGARDE, M. Prostaglandines et fonctions plaquettaires. Etude des variations de la prostaglandine El et de TAMP cyclique au cours des thromboses veineuses post-opératoires. Med. Afr. Noire, 23 (n.° especial); Congrés Français de Médecine, 40e., Dec. 1975, p. 29-34.
34. ROSE, P. & MCDOUGALL, C. Adverse reactions following pregnancy in patients with borderline (dimorphous' leprosy). Lepr. Rev., 46(2): 109-114, 1975.
35. SAHA, K.; DUTRA, R. N.; MITTAL, M. M. Immunologic aspects of leprosy as related to leucocytic Isoantibodies and platelet aggregating factors. Int. J. Lepr., 43(3): 239-248, 1975.
36. SINGH, R. K.; CHANSOURIA, J. P.; UDUPA, K. N. Alterationes in urinary 17-ketosteroid levels following major and minor surgical operations. Indian J. Med. Res., 63(2): 253-255, 1975.
37. STEVEN, R.; COHEN, P. D.; HERNDON, R. M.; MCKHANN, G. M. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. New England J. Med., 295(26): 1455-1457, 1976.
38. STIMSON, W. H. Immunosuppressive effect of pregnancy-associated Alpha,-Macroglobilin Lancet, 2(7942): 989, 1975.
39. TEMINE, P. Les altérations vasculaires au cours des dermatoses et leur traitement. Coeur méd. Interne, 8(3): 353-361, 1969.
40. TOLENTINO, J. G.; RODRIGUEZ, J. N.; ABALOS, R. M. Controlled long-term therapy of leprosy with B663 (Lamprene, Clofazimine) compared with DDS. Int. J. Lepr., 42(4): 416-418, 1974.
41. WATERS, M. F. R. Modern advances in the immunology of leprosy. Papua N. Guinea Med. J., 16(2): 86-92, 1973.
42. WATERS, M. F. R.; TURK, J. L.; WEMAMBU, S. N. C. Mechanisms of reactions in leprosy. Int. J. Lepr., 39(2): 417-428, 1971.
43. WEDDEL, A. G. M. & PEARSON, J. M. H. Leprosy. Histopathologic aspects of nerve involvement. Topics on Tropical neurology. Cap. 1, 1973, p. 17-28.
44. WEISER, R. S. Antitissue versus antimicrobial cellular immunity: a perspective. J.Reticuloendothel. Soc., 10: 17-27, 1971.
45. WELLER, R. O.; BRUCKNER, F. E.; CHAMBERLAIN, M. A. Rheumatoid neuropathy:ahistological and electro-physiological study. J. Neurol. Neurosurg. Psychiatry, 33: 592-604, 1970.
46. WISNIEWSKI, H. M. & BLOOM, B. R. Primary demyelination as a nonspecific consequence of cell-mediated immune reaction. J. Exp. Med., 141: 346-359, 1975. Reçu le 30 avril 1977
2. BARNETSON, R.; BARNETSON, A.; PEARSON, J. M. H.; KRONVALL, G Does nonspecific T-lymphocyte stimulation of B. lymphocytes occur during reversal reactions in bordeline leprosy?Scand. J. Immunol., 5(3): 287-291, 1976.
3. BARNETSON, R. S. G.; BRINE, G.; PEARSON, J. M. H.; KRONVALL, G Antigenic heterogeneity in patients with reactions in bordeline leprosy. Brit. Med. J., 22: 435-437, 1975.
4. BASTIN, R.; CHARMONT, G.; BONIZZONI, D.; GIROUIN, D.; KERNBAUM, S.; BRICAIRE.. F.; DIF, A. La lépre lepromateuse. Contre-indication méconnue de la vaccination antivariolique. Nouv. Presse Med., 5(17):1143-1144, 1976.
5. BENSASSON, M. Les neuropathies périphériques. Le Contours médica!, 98(47): 7549, 1976.
6. BENSOUSSAN, D.; LEVY-TOLEDANO, S.; PASSA, P. Anomalies de l'hémostase primaire au cours de la microangipathie diabétique. Nouv. Presse Med., 5(36): 2383-2386, 1976.
7. BERNARD, J. C. Estudio anatomopatologi co de las lesions vasculares del lepromatoso. Leprologia, 18(3): 239-267, 1973.
8. BODDINGIUS, J. Ultrastructural changes in blood vessels of peripheral nerves in leprosy neuropathy. 1. Tuberculoid and bordeline-Tuberculoid leprosy patients. Acta Neuropathol. (Berl), 35: 159-181, 1976.
9. BOUSSER, M. G. L'offensive des antiagrégants plaquettaires. L'année du Praticien, 26(59): 4265-4271, 1976.
10. CARAYON, A. Gamme lésionnelle des névrites hanséniennes. (Etat actuei des acquisitions récentes et des orientations thérapeutiques). Méd. Trop., 36(1): 41-61, 1976.
11. CARAYON, A.; CAMAIN, R.; BOURREL, P.; COLOMAR, R. Confrontationanatomo-clinique et angiopathique pour multinévrite tuber culoide réactionnelle. C. R. Trim. Inst. Marchoux, 7(3): 14-22, 1966; Bull. Soc. Med. Afr. Noire Lang. Fr., 11(2): 273-281, 1966.
12. CARAYON, A. & LANGUILLON, J. Traitement de la lépre tuberculoide par les sulfamides, retard. Afr. Méd., 44: 599, 1966.
13. CARAYON, A.; LANGUILLON, J.; GIRAUDEAU, P.; CAMAIN, R.; MAYDAT, L. Névri - tes micro-angiopathiques d'origine auto-immume probable après migrations inverses dans la zone bordeline du spectre de la lépre. Méd. Trop. 36(1): 16-33, 1976.
14. CARAYON, A.; LANGUILLON, J.; MAYDAT, L.; FAYE, I.; BOURGES, M. Deuxcasd'abces. lépromateux aigus du nerf cubital. Bull.Soc. Med. Afr. Noire Lang. Fr., 14(4) : 659-662, 1969.
15. CHOVET, M.; LUCOT, J.; SAINT-ANDRE, P.; VINGTAIN, P. Lesatteintesoculairesdansla lépre. Med. Trop. 36(1): 34-40, 1976.
16. CONN. D. L.; MCDUFFIE, F. C.; HOLLEY, K. E.; SCHROETER, A. L. Immunologic mechanisms in systemic vasculitis. Mayo Clin. Proc., 51: 511-518, 1976.
17. CONTAMIN, F.; SINGER, B.; MIGNOT, B.; ECOFFET, M.; KAZATCHKINE, M. Polineuropathie à rechutes. Rev. Neurol., (Paris) 132(11): 741-762, 1976.
18. DIEBOLD, J. & CAMILLERI, J. P. Macro et micro-angiopathies diabétiques. Aspects anatomopathologiques. Rev. Praticien, 26(45): 3075-3082, 1976.
19. GANDULY, R.; CUSUMANO, C. L.; WALDMAN, R.H. Suppression of cell-mediated immunity after infection with attenuated rubela virus. Infect. Immun.. 13(2): 464-469, 1976.
20. GHOSH, S. & KUNDU, K. K. Nerve abcess in lepromatous leprosy. Leprosy India, 41(1) : 11-13, 1969. i'
21. GUPTA, M.; BHARGAVA, M.; KUMAR, S.; MITTAL, M. M. Platelet function in leprosy. Int. J. Lepr., 43(4): 327-332, 1975.
22. HAUTECOUVERTURE, M.; BASDEVANT, A.; SLAMA, G.; TCHOBROUTSCKY, G. Etiopathogénie, physiopathologie et épidémiologie de la micro-angiopathie diabètique. Rev. Praticien, 26(45): 3085-3093, 1976.
23. KAUR, S.; WAHI, P. L.; CHAKRAVARTI, R. N.; SODHI, J. S.; VADHWA, M. B.; KHERA, A. S. Peripheral vascular deficit in leprosy. Int. J. Lepr., 44(3): 332-339, 1976.
24. LAMBERT, P. H. & MIESCHER, P. A. Aspect dynamique de la pathogénie des vasculites d'origine immunologique. Schweiz. Med. Wochenschr., 101: 1797-1798, 1971.
25. LETONTURIER, P. La microangiopathie diabétique. Nouv. Presse Méd., 5(36): 2365-2366, 1976.
26. MEHRA, N. K.; DASGUPTA, A.; VAIDYA, M. C. An evaluation of the immune state in leprosy. Leprosy India, 48(3): 231-237, 1976.
27. MUNSTER, A. M. Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet, 1(7973): 1329-1330, 1976.
28. PARDO CASTELLO, V. & PINEYRO, R. Los cambios anatomo-patologicos de los nervios en la lepra lepromatosa. Rev. Sifil. Leprol. Dermatol., 5(2): 265-269, 1948.
29. PARMASWARAN, M.; GIRDHAR, B. K.; DEO, M. G.; KANDHARI, K. C.; BHUTANI, L. K. Macrophage function in leprosy. Int. J. Lepr., 44(3): 340-345, 1976.
30. PEARSON, J. M. H. & ROSS, W. F. Nerve involvement in leprosy. Pathology, differential diagnosis and principles of management. Lepr. Rev., 46(3): 199-212, 1975.
31. PIRART, J. Place et responsabilités des lesions vasculaires dans les neuropaties diabétiques. Rev. Praticien, 26(45): 3149-3156, 1976.
32. POLLARD, J. D.; KING, R. H.; THOMAS P. K. Recurrent experimental allergic neuritis. An electron microscope study. J. Neurol. Sci., 24(3): 365-383, 1975.
33. REVOL, L.; DECHAVANNE, M.; LAGARDE, M. Prostaglandines et fonctions plaquettaires. Etude des variations de la prostaglandine El et de TAMP cyclique au cours des thromboses veineuses post-opératoires. Med. Afr. Noire, 23 (n.° especial); Congrés Français de Médecine, 40e., Dec. 1975, p. 29-34.
34. ROSE, P. & MCDOUGALL, C. Adverse reactions following pregnancy in patients with borderline (dimorphous' leprosy). Lepr. Rev., 46(2): 109-114, 1975.
35. SAHA, K.; DUTRA, R. N.; MITTAL, M. M. Immunologic aspects of leprosy as related to leucocytic Isoantibodies and platelet aggregating factors. Int. J. Lepr., 43(3): 239-248, 1975.
36. SINGH, R. K.; CHANSOURIA, J. P.; UDUPA, K. N. Alterationes in urinary 17-ketosteroid levels following major and minor surgical operations. Indian J. Med. Res., 63(2): 253-255, 1975.
37. STEVEN, R.; COHEN, P. D.; HERNDON, R. M.; MCKHANN, G. M. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. New England J. Med., 295(26): 1455-1457, 1976.
38. STIMSON, W. H. Immunosuppressive effect of pregnancy-associated Alpha,-Macroglobilin Lancet, 2(7942): 989, 1975.
39. TEMINE, P. Les altérations vasculaires au cours des dermatoses et leur traitement. Coeur méd. Interne, 8(3): 353-361, 1969.
40. TOLENTINO, J. G.; RODRIGUEZ, J. N.; ABALOS, R. M. Controlled long-term therapy of leprosy with B663 (Lamprene, Clofazimine) compared with DDS. Int. J. Lepr., 42(4): 416-418, 1974.
41. WATERS, M. F. R. Modern advances in the immunology of leprosy. Papua N. Guinea Med. J., 16(2): 86-92, 1973.
42. WATERS, M. F. R.; TURK, J. L.; WEMAMBU, S. N. C. Mechanisms of reactions in leprosy. Int. J. Lepr., 39(2): 417-428, 1971.
43. WEDDEL, A. G. M. & PEARSON, J. M. H. Leprosy. Histopathologic aspects of nerve involvement. Topics on Tropical neurology. Cap. 1, 1973, p. 17-28.
44. WEISER, R. S. Antitissue versus antimicrobial cellular immunity: a perspective. J.Reticuloendothel. Soc., 10: 17-27, 1971.
45. WELLER, R. O.; BRUCKNER, F. E.; CHAMBERLAIN, M. A. Rheumatoid neuropathy:ahistological and electro-physiological study. J. Neurol. Neurosurg. Psychiatry, 33: 592-604, 1970.
46. WISNIEWSKI, H. M. & BLOOM, B. R. Primary demyelination as a nonspecific consequence of cell-mediated immune reaction. J. Exp. Med., 141: 346-359, 1975. Reçu le 30 avril 1977
Descargas
Publicado
1977-06-30
Cómo citar
1.
CARAYON A. Les névrites microangiopathiques dans la lèpre. Hansen. Int. [Internet]. 30 de junio de 1977 [citado 30 de junio de 2024];2(1):15-23. Disponible en: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35654
Número
Sección
Articulos originales
Licencia
Esta revista tiene la licencia Creative Commons Attribution 4.0 International License.
